Literature DB >> 28327805

Antifungal activity of synthetic antiseptics and natural compounds against Candida dubliniensis before and after in vitro fluconazole exposure.

Cássia Franco Reginato1, Laíssa Arévalo Bandeira2, Régis Adriel Zanette3, Janio Morais Santurio4, Sydney Hartz Alves4, Cristiane Cademartori Danesi5.   

Abstract

INTRODUCTION: : This study evaluated the susceptibilities of oral candidiasis-derived Candida albicans, fluconazole-resistant (FR) Candida dubliniensis, and fluconazole-susceptible (FS) C. dubliniensis to synthetic antiseptics [chlorhexidine gluconate (CHX), cetylpyridinium chloride (CPC), and triclosan (TRC)] and natural compounds (carvacrol, eugenol and thymol).
METHODS: : Susceptibility tests were performed based on the M27-A3 reference method. The fluconazole-resistant C. dubliniensis strains were obtained after prolonged in vitro exposure to increasing fluconazole concentrations. The geometric mean values for minimum inhibitory concentrations and minimum fungicidal concentrations were compared among the groups.
RESULTS: : Fluconazole-susceptible C. dubliniensis was more sensitive to CPC and TRC than FR C. dubliniensis and C. albicans were. However, eugenol and thymol were more active against FR C. dubliniensis. The fungicidal activities of CHX and TRC were similar for the three groups, and FR C. dubliniensis and C. albicans had similar sensitivities to CPC.
CONCLUSIONS: : The resistance of C. dubliniensis to fluconazole affects its sensitivity the synthetic antiseptics and natural compounds that were tested.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28327805     DOI: 10.1590/0037-8682-0461-2016

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  1 in total

1.  Glass ionomer cement modified by a imidazolium salt: adding antifungal properties to a biomaterial.

Authors:  Alexandre Ehrhardt; Jéssica Zolim Andreatto Mandelli; Vanessa Bérgamo; William Lopes; Ricardo Keitel Donato; Régis A Zanette; Alexandre Meneghello Fuentefria
Journal:  Braz J Microbiol       Date:  2021-05-05       Impact factor: 2.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.